Trial Profile
A retrospective, observational study of abatacept in patients with systemic-lupus-erythematosus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Systemic lupus erythematosus
- Focus Adverse reactions; Therapeutic Use
- 24 Aug 2016 New trial record